Hi Howie,
Not my specific wheel house. But we now have 15 trial sites in the USA and Australia ready for Azercel enrollments.
Clinicians recommend the trial that they believe is best suited for the patient.
Group B results. 3 from 3, two of which being cures, from patients that have failed all previous lines of therapy. (Absolutely remarkable when you think about it). This should really bump up visibility and desire to enrol from clinicians.
So long as this is not a fluke being we got lucky on the first two in. The buzz around DLBCL community will build, and I see no issue in enrolments and they'll build this out to 10 patients in next to no time relative to how long trials take (call it 6 months) (which I believe is the minimum data set to talk with the FDA)
Not advice DYOR.
Hi Howie,Not my specific wheel house. But we now have 15 trial...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
0.006(9.68%) |
Mkt cap ! $499.7M | |||
| Open | High | Low | Value | Volume |
| 7.3¢ | 8.1¢ | 6.7¢ | $14.56M | 194.2M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 605784 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 159880 | 2 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |